Clinical Trial Update: 5 vs. 9-day Course of Whole Breast Radiotherapy With Boost for Early-stage Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study comparing 5-day versus 9-day courses of whole breast radiotherapy with a boost for early-stage breast cancer; the trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ of the Breast
• Invasive Breast Carcinoma

Snippet

Sponsor: University of Utah | Conditions: Breast Cancer, Invasive Carcinoma of Breast | Phase 2 | Status: RECRUITING